不同的主调节者定义近距离和远距离胃癌:对预后和向治疗的机会的洞察
Luigi Marano1,2,3,4, Salvatore Sorrenti5, Silvia Malerba6
1Department of Medicine, Academy of Applied Medical and Social Sciences-AMiSNS (Akademia Medycznych I Spolecznych Nauk Stosowanych), 52-300 Elbląg, Poland.
Current oncology (Toronto, Ont.)
|August 27, 2025
概括
靠近胃癌 (PGC) 比偏远胃癌 (DGC) 更具侵略性,由PGC中的FOXM1和DGC中的CDX2等不同的主调节器驱动. 这些分子差异影响患者的治疗结果和治疗策略.
科学领域:
- 癌症学
- 基因组学
- 分子生物学
背景情况:
- 胃癌 (GC) 呈现出显著的异质性,瘤的位置影响了预后和治疗反应.
- 靠近胃癌 (PGC) 和远距离胃癌 (DGC) 是不同的亚型,具有不同的临床和分子特征.
研究的目的:
- 通过主调节器 (MR) 分析,研究PGC和DGC之间的转录和监管区别.
- 识别关键的分子驱动因素和信号通路,使PGC与DGC有所区别.
主要方法:
- 来自TCGA-STAD的RNA序列数据和来自GEO (GSE62254,GSE15459) 的微阵列数据的分析.
- 使用DESeq2,limma,corto和RegEnrich管道进行差异性基因表达和MR分析.
- 功能丰富和生存分析以评估预后影响.
主要成果:
- 与DGC相比,PGC病例表现出更激烈的特征和更差的结果.
- 在PGC和DGC之间鉴定了998个差异表达基因 (DEG).
- PGC的特征是FOXM1,STAT3和NF-κB1的活性增加,而DGC显示了GATA6,CDX2和HNF4A信号的丰富.
- 功能丰富揭示了PGC中的增殖/炎症程序和DGC中的差异化/代谢途径.
结论:
- PGC和DGC是由不同的转录网络和信号通路调节的.
- 主调节器分析提供了通过解剖位置分层胃癌的生物学基础.
- 这些发现支持开发针对PGC和DGC的特定分子特征的向疗法.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.6K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.3K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
